Cargando…
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047475/ https://www.ncbi.nlm.nih.gov/pubmed/30027105 http://dx.doi.org/10.1212/NXI.0000000000000479 |
_version_ | 1783339950521974784 |
---|---|
author | Scheibe, Franziska Metz, Imke Radbruch, Helena Siebert, Eberhard Wolf, Stefan Köhnlein, Martin Harms, Lutz Meisel, Andreas |
author_facet | Scheibe, Franziska Metz, Imke Radbruch, Helena Siebert, Eberhard Wolf, Stefan Köhnlein, Martin Harms, Lutz Meisel, Andreas |
author_sort | Scheibe, Franziska |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6047475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-60474752018-07-19 Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS Scheibe, Franziska Metz, Imke Radbruch, Helena Siebert, Eberhard Wolf, Stefan Köhnlein, Martin Harms, Lutz Meisel, Andreas Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2018-07-10 /pmc/articles/PMC6047475/ /pubmed/30027105 http://dx.doi.org/10.1212/NXI.0000000000000479 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Clinical/Scientific Notes Scheibe, Franziska Metz, Imke Radbruch, Helena Siebert, Eberhard Wolf, Stefan Köhnlein, Martin Harms, Lutz Meisel, Andreas Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS |
title | Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS |
title_full | Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS |
title_fullStr | Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS |
title_full_unstemmed | Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS |
title_short | Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS |
title_sort | drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in ms |
topic | Clinical/Scientific Notes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047475/ https://www.ncbi.nlm.nih.gov/pubmed/30027105 http://dx.doi.org/10.1212/NXI.0000000000000479 |
work_keys_str_mv | AT scheibefranziska drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms AT metzimke drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms AT radbruchhelena drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms AT sieberteberhard drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms AT wolfstefan drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms AT kohnleinmartin drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms AT harmslutz drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms AT meiselandreas drugreactionwitheosinophiliaandsystemicsymptomsafterdaclizumabtherapyinms |